Nivolumab may extend survival in HCC patientsNovember 7, 2017ImmunotherapyGastroenterologyGastrointestinal Cancer
Endoscopic therapy effective for early cancer in Barrett’s esophagusOctober 27, 2017GastroenterologyGastrointestinal Cancer
Barrett’s esophagus length predicts disease progressionOctober 26, 2017GastroenterologyGastrointestinal Cancer
Biosimilars poised to save $54 billion over the next decadeOctober 25, 2017Practice ManagementGastroenterologyGastrointestinal Cancer
Survey colonoscopy outpatients to flag high cancer riskOctober 24, 2017GastroenterologyGastrointestinal Cancer
Pilot study: Novel spray powder stops GI bleedingOctober 18, 2017GastroenterologyGastrointestinal Cancer
Worse survival with cetuximab plus chemo for CRC liver metsOctober 2, 2017GastroenterologyGastrointestinal Cancer
Robot-assisted abdominoperineal resection outperforms open or laparoscopic surgery for rectal cancersSeptember 29, 2017GastroenterologyGastrointestinal Cancer
FDA approves pembrolizumab for gastric and GEJ adenocarcinomaSeptember 27, 2017GastroenterologyImmuno-oncologyGastrointestinal Cancer
Study shows childhood IBD increased cancer risk in adulthoodSeptember 27, 2017GastroenterologyPediatricsGastrointestinal Cancer
Consider adding chemotherapy after GI surgerySeptember 26, 2017GastroenterologyGastrointestinal Cancer
FDA approves nivolumab for HCC patientsSeptember 25, 2017GastroenterologyImmuno-oncologyGastrointestinal Cancer
FDA approves biosimilar to bevacizumabSeptember 14, 2017GastroenterologyLung CancerGynecologic CancerCNS/Brain CancerRenal Cell CarcinomaNeuro-oncologyGastrointestinal Cancer
Minimally invasive esophagectomy may mean less major morbiditySeptember 9, 2017GastroenterologyGastrointestinal Cancer
Reduced starting dose of sorafenib for HCC appears safeSeptember 7, 2017GastroenterologyGastrointestinal Cancer